English  |  正體中文  |  简体中文  |  2816755  
???header.visitor??? :  27594024    ???header.onlineuser??? :  496
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"reich k"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-11 of 11  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2022 International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis Van, Huizen A.M.;Menting, S.P.;Gyulai, R.;Iversen, L.;Van, Der Kraaij G.E.;Middelkamp-Hup, Middelkamp-Hup M.A.;Warren, R.B.;Spuls, P.I.;Schejtman, A.A.;Egeberg, A.;Firooz, A.;Kumar, A.S.;Oakley, A.;Foulkes, A.;Ramos, A.M.C.;Fougerousse, A.-C.;Čarija, A.;Akman-Karakaş, Akman-Karakaş A.;Horváth, B.;Fábos, B.;Matlock, B.H.;Claréus, B.W.;Castro, Castro C.;Ferrándiz, C.;Correa, Correa C.C.;Marchesi, C.;Goujon, C.;Gonzalez, C.;Maldonado-García, C.;Hong, C.-H.;Griffiths, C.E.M.;Vestergaard, C.;Echeverría, C.M.;De, La Cruz C.;Conrad, Conrad C.;Törőcsik, D.;Drvar, Drvar D.L.;Balak, D.;Jullien, D.;Appelen, D.;Kim, D.H.;De, Jong E.M.G.J.;El, Gamal E.;Laffitte, E.;Mahé, E.;Sonkoly, E.;Colombo, E.P.;Vilarrasa, E.;Willaert, F.;Novoa, F.D.;Handjani, F.;Valenzuela, F.;Vílchez-Márquez, F.;Gonzalez, Gonzalez G.O.;Krisztián, G.;Damiani, G.;Krnjević-Pezić, G.;Pellerano, G.;Carretero, G.;Hunter, Hunter H.J.A.;Riad, H.;Oon, H.H.;Boonen, H.P.J.;Moussa, I.O.;García-Doval, I.;Csányi, I.;Brajac, I.;Turchin, I.;Grozdev, I.;Weinberg, J.M.;Nicolopoulos, J.;Wells, J.;Lambert, J.L.W.;Ingram, J.R.;Prinz, J.C.;De, Souza Sittart J.A.;Sanchez, J.L.;Hsiao, J.P.-F.;Castro-Ayarza, J.R.;Maul, J.-T.;Van, Den Reek J.M.P.A.;Trčko, K.;Barber, K.;Reich, K.;Gebauer, K.A.;Khobzei, Khobzei K.;Maul, L.V.;Massari, L.P.;Fardet, L.;Le, Cleach L.;Misery, L.;Chandrashekar, L.;Muresanu, L.I.;Lecluse, Lecluse L.;Skov, L.;Frez, M.L.;Babić, L.T.;Puig, L.;Gomez, L.C.;Ramam, M.;Dutil, M.;El-Sayed, M.H.;Olszewska, M.;Schram, M.E.;Franco, M.D.;Llamas-Velasco, M.;Gonçalo, M.;Velásquez-Lopera, M.M.;Abad, M.E.;De, Oliveira M.D.F.S.P.;Seyger, M.M.B.;Kaštelan, M.;Rademaker, M.;Sikora, M.;Lebwohl, M.;Wiseman, M.C.;Ferran, M.;Van, Doorn M.;Danespazhooh, M.;Bylaitė-Bucinskiene, M.;Gooderham, M.J.;Polić, M.V.;De, Rie M.A.;Zheng, M.;Gómez-Flores, M.;Salleras, I Redonnet M.;Silverberg, N.B.;Doss, N.;Yawalkar, N.;Chosidow, O.;Zargari, O.;De, La Cueva P.;Fernandez-Peñas, Peñas P.;Cárdenas, Rojas P.J.;Gisondi, P.;Grewal, P.;Sator, P.;Luna, P.C.;Félix, P.A.O.;Varela, P.;Holló, P.;Cetkovska, P.;Calzavara-Pinton, Pinton P.;Ghislain, P.-D.;Araujo, R.R.;Romiti, Romiti R.;Kui, R.;Čeović, R.;Vender, R.;Lafuente-Urrez, R.F.;Del-Río, Río R.;Gulin, S.J.;Handa, S.;Mahil, S.K.;Kolalapudi, S.A.;Marrón, S.E.;Azimi, S.Z.;Janmohamed, S.R.;Da, Cruz Costa S.A.;Choon, S.E.;Urbancek, S.;Ayanlowo, O.;Margasin, S.M.;Wong, T.-W.;Mälkönen, T.;Hurtová, T.;Reciné, T.R.;Huldt-Nystrøm, T.;Torres, Torres T.;Liu, T.-Y.;Leonidze, T.;Sharma, V.K.;Weightman, Weightman W.;Gulliver, W.;Veldkamp, W.;Group, The SPIN MTX Consensus Survey Study
國立成功大學 2022 Transcriptomic Analysis of Blaschko-Linear Psoriasis Reveals Shared and Distinct Features with Psoriasis Vulgaris Onoufriadis, A.;Niazi, U.;Dimitrakopoulou, K.;Reich, J.;Ainali, C.;Papanikolaou, M.;Kesidou, E.;Hsu, C.-K.;Saqi, M.;McGrath, J.A.;Reich, K.
臺大學術典藏 2020-10-22T07:28:03Z Secukinumab in plaque psoriasis - Results of two phase 3 trials Karpov A.; Hampele I.; Notter M.; Salko T.; Tyring S.; Langley R.G.; Elewski B.E.; Lebwohl M.; Reich K.; Griffiths C.E.M.; Papp K.; Puig L.; Nakagawa H.; Spelman L.; Sigurgeirsson B.; Rivas E.; TSEN-FANG TSAI; Wasel N.; Helou S.; Papavassilis C.
臺大學術典藏 2020-10-22T07:27:58Z Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial Tha?i D.; Blauvelt A.; Reich K.; TSEN-FANG TSAI; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Hugot S.; You R.; Milutinovic M.
臺大學術典藏 2020-10-22T07:27:55Z Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis Fox T.; Papavassilis C.; Huang J.; Gong Y.; TSEN-FANG TSAI; Blauvelt A.; Leonardi C.L.; Griffiths C.E.M.; Reich K.; Van De Kerkhof P.C.M.
臺大學術典藏 2020-10-22T07:27:53Z Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1?year: Results from the CLEAR study Blauvelt A.; Reich K.; TSEN-FANG TSAI; Tyring S.; Vanaclocha F.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Hugot S.; You R.; Milutinovic M.; Tha?i D.
臺大學術典藏 2020-10-22T07:27:40Z Consistent responses with guselkumab treatment in Asian and non-Asian patients with psoriasis: An analysis from VOYAGE 1 and VOYAGE 2 Reich K.;Song M.;Li S.;Jiang J.;Youn S.W.;Tsen-Fang Tsai;Choe Y.B.;Huang Y.-H.;Gordon K.B.; Reich K.; Song M.; Li S.; Jiang J.; Youn S.W.; TSEN-FANG TSAI; Choe Y.B.; Huang Y.-H.; Gordon K.B.
臺大學術典藏 2019 Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial Krueger J.G.; TSEN-FANG TSAI; Flack M.; Gu Y.; Williams D.A.; Thompson E.H.Z.; Paul C.; Ryan C.; Crowley J.J.; Tha?i D.; Reich K.; Gooderham M.
臺大學術典藏 2019 Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study Tha?I D.;Puig L.;Reich K.;Tsen-Fang Tsai;Tyring S.;Kingo K.;Ziv M.;Pinter A.;Vender R.;Lacombe A.;Xia S.;Bhosekar V.;Gilloteau I.;Guana A.;Blauvelt A.; Tha?i D.; Puig L.; Reich K.; TSEN-FANG TSAI; Tyring S.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Lacombe A.; Xia S.; Bhosekar V.; Gilloteau I.; Guana A.; Blauvelt A.
國立臺灣大學 2016 Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies Foley, P.; Griffiths, C.; Reich, K.; Leonardi, C. L.; Blauvelt, A.; Mehta, N. N.; Tsai, T. F.; Gong, Y.; Papavassilis, C.; Huang, J.; Fox, T.; van de Kerkhof, P.; 蔡呈芳
國立臺灣大學 2016 Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study Rubel, D.; Thaci, D.; Blauvelt, A.; Reich, K.; Tsai, T. F.; Vanaclocha, F.; Kingo, K.; Ziv, M.; Pinter, A.; Hugot, S.; You, R.; Augustin, M.; Milutinovic, M.; 蔡呈芳

Showing items 1-11 of 11  (1 Page(s) Totally)
1 
View [10|25|50] records per page